Loading…
Wednesday, May 15 • 2:00pm - 2:45pm
Efficacy of Ketamine in the Treatment of Substance Use Disorders

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Ketamine has shown preliminary promise as a rapid-acting antidepressant. Now, a growing body of research is exploring ketamine's potential in treating addiction as well. In this session, leading experts will review mounting evidence surrounding ketamine-assisted therapy for substance use disorders. They will discuss proposed mechanisms of action, results from clinical trials, ideal patient profiles, implementation considerations, and next steps in evaluating ketamine's efficacy as an addiction treatment.

*This session qualifies for CME. 
Speakers
avatar for Jennifer L. Jones, MD

Jennifer L. Jones, MD

Assistant Professor, Medical University of South Carolina
avatar for Elias Dakwar, MD

Elias Dakwar, MD

​​Associate Professor of Clinical Psychiatry, Columbia University School of Medicine
Elias Dakwar has been researching novel treatments for addictions for over a decade, with the support of several grants from the National Institutes of Health. A special focus of his research has been evaluating sub-anesthetic ketamine infusions for cocaine use disorders in both laboratory... Read More →

Wednesday May 15, 2024 2:00pm - 2:45pm EDT
  Accredited CME Session
Feedback form isn't open yet.